3 VM 1001 topical cream - CDA Research Group

Drug Profile

3 VM 1001 topical cream - CDA Research Group

Alternative Names: 3VM1001 cream - CDA Research Group

Latest Information Update: 10 May 2017

Price : $50

At a glance

  • Originator CDA Research Group
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Pain
  • Phase I Osteoarthritis

Most Recent Events

  • 30 Apr 2017 Phase-I/II clinical trials in Pain in USA (Topical) (NCT03142178)
  • 09 Aug 2016 Phase-I clinical trials in Osteoarthritis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top